These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1437 related items for PubMed ID: 11787527

  • 21. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS, Li S, Colson YL, Demetris AJ, Neipp M, Ildstad ST, Pham SM.
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [Abstract] [Full Text] [Related]

  • 22. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 23. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.
    J Surg Res; 2010 May 15; 160(2):315-24. PubMed ID: 19524257
    [Abstract] [Full Text] [Related]

  • 24. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 25. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD, Liu JY, Timrott KF, Popp FC, Stoeltzing O, Lang SA, Piso P, Geissler EK, Schlitt HJ, Dahlke MH.
    Exp Hematol; 2007 Jan 15; 35(1):164-70. PubMed ID: 17198885
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ, Izycki DM, Zielinski M.
    Transplantation; 2003 Dec 27; 76(12):1662-8. PubMed ID: 14688512
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
    Jankowski RA, Ildstad ST.
    Hum Immunol; 1997 Feb 27; 52(2):155-61. PubMed ID: 9077564
    [Abstract] [Full Text] [Related]

  • 30. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Feb 27; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, Swenson KG, Zhao G, Sykes M.
    Transplantation; 1999 Nov 15; 68(9):1348-55. PubMed ID: 10573075
    [Abstract] [Full Text] [Related]

  • 35. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H, Takeuchi Y, Shaffer J, Sykes M.
    Transplantation; 2006 Jul 27; 82(2):251-7. PubMed ID: 16858289
    [Abstract] [Full Text] [Related]

  • 36. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H, Abe M, Shirai T, Fukao K, Nakauchi H.
    J Immunol; 1995 Dec 15; 155(12):5631-6. PubMed ID: 7499847
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2004 Nov 15; 32(11):1110-7. PubMed ID: 15539090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.